AbbVie Inc.
ABBVNYSE
$284.60
Last price · USD
- Market cap
- $504.9B
- P/E
- 120.1x
- EV / EBITDA
- 32.3x
- P/S
- 8.3x
- FCF yield
- 3.5%
- Div. yield
- 2.31%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
AbbVie Inc. key metrics & ratios
Annual · USD millions except per-share data · 36 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | 8.6% | 3.7% | -6.4% | 3.3% | — | — | |
| Operating income growth | 119.9% | -28.4% | -29.6% | 1.1% | — | — | |
| Net income growth | -1.2% | -12.0% | -58.9% | 2.5% | — | — | |
| EPS (diluted) growth | -0.8% | -12.1% | -59.0% | 2.8% | — | — | |
| Free cash flow growth | -0.1% | -19.2% | -9.0% | 10.3% | — | — | |
| Margins | |||||||
| Gross margin | 70.2% | 70.0% | 62.4% | 70.0% | 69.0% | — | |
| Operating margin | 32.8% | 16.2% | 23.5% | 31.2% | 31.9% | — | |
| EBITDA margin | 28.8% | 26.5% | 31.6% | 41.6% | 42.6% | — | |
| Net margin | 6.9% | 7.6% | 9.0% | 20.4% | 20.5% | — | |
| FCF margin | 29.1% | 31.7% | 40.6% | 41.8% | 39.1% | — | |
| Returns on capital | |||||||
| Return on equity | — | 128.7% | 46.9% | 68.6% | 74.9% | — | |
| Return on assets | 3.2% | 3.2% | 3.6% | 8.5% | 7.9% | — | |
| Return on invested capital | 21.3% | 13.9% | 17.2% | 22.0% | 19.1% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | — | 20.40x | 5.80x | 3.72x | 5.03x | — | |
| Net debt / EBITDA | 3.62x | 4.18x | 2.75x | 2.27x | 2.83x | — | |
| Current ratio | 0.67x | 0.66x | 0.87x | 0.96x | 0.79x | — | |
| Interest coverage | 6.94x | 3.25x | 5.74x | 8.12x | 7.40x | — | |
| Profitability & operating | |||||||
| EBIT | 9,490 | 6,524 | 8,474 | 15,707 | 15,412 | -11.4% | |
| EBITDA | 17,629 | 14,910 | 17,172 | 24,174 | 23,933 | -7.4% | |
| Operating income | 20,091 | 9,137 | 12,757 | 18,117 | 17,924 | +2.9% | |
| Income before tax | 6,597 | 3,716 | 6,250 | 13,477 | 12,989 | -15.6% | |
| Net income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 | -22.2% | |
| Earnings per share | |||||||
| EPS (basic) | $2.37 | $2.40 | $2.73 | $6.65 | $6.48 | -22.2% | |
| EPS (diluted) | $2.37 | $2.39 | $2.72 | $6.63 | $6.45 | -22.1% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 1,774 | 1,769 | 1,768 | 1,771 | 1,770 | +0.1% | |
| Weighted avg shares outstanding (diluted) | 1,774 | 1,773 | 1,773 | 1,778 | 1,777 | 0.0% | |
| Balance sheet highlights | |||||||
| Net debt | 63,839 | 62,317 | 47,306 | 54,990 | 67,829 | -1.5% | |
| Total debt | 69,068 | 67,841 | 60,120 | 64,191 | 77,575 | -2.9% | |
| Total investments | 327 | 310 | 306 | 269 | 361 | -2.4% | |
| Total stockholders' equity | (3,270) | 3,325 | 10,360 | 17,254 | 15,408 | — | |
| Total assets | 133,960 | 135,161 | 134,711 | 138,805 | 146,529 | -2.2% | |
| Cash flow highlights | |||||||
| Free cash flow | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 | -5.1% | |
| Operating cash flow | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 | -4.4% | |
| Capital expenditure | (1,214) | (974) | (777) | (695) | (787) | — | |
| Net cash from operating activities | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 | -4.4% | |
| Additional fields | |||||||
| Accrued Expenses | 2,219 | 1,986 | 1,802 | 1,371 | 1,785 | +5.6% | |